Cargando…
Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and Oocytes
Although microtubule-associated serine/threonine kinase-like (MASTL) is a promising target for selective anticancer treatment, MASTL inhibitors with nano range potency and antitumor efficacy have not been reported. Here, we report a novel potent and selective MASTL inhibitor MASTL kinase inhibitor-2...
Autores principales: | Kang, Minsung, Kim, Chijung, Leem, Jiyeon, Kim, Ye-hyun, Kwon, Young-ju, Yoon, Yi Na, Chae, Chong Hak, Ahn, Jiyeon, Jung, Kwan-Young, Oh, Jeong Su, Kim, Jae-Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308786/ https://www.ncbi.nlm.nih.gov/pubmed/34358073 http://dx.doi.org/10.3390/ph14070647 |
Ejemplares similares
-
MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast Cancer
por: Kim, Ah-Young, et al.
Publicado: (2020) -
Kinase-Independent Functions of MASTL in Cancer: A New Perspective on MASTL Targeting
por: Conway, James Ronald William, et al.
Publicado: (2020) -
The Oncogenic Functions of MASTL Kinase
por: Marzec, Kamila, et al.
Publicado: (2018) -
Mastl/PP2A regulate Cdk1 in ooycte maturation
por: Adhikari, Deepak, et al.
Publicado: (2015) -
MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells
por: Yoon, Yi Na, et al.
Publicado: (2018)